A Phase I Open-label Study for Subjects With Advanced Malignancies
NCT04136834
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
62
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Malignancies
Interventions
BIOLOGICAL:
PT01 (Pegtomarginase)
Sponsor
Athenex, Inc.